There are plenty of AI startups on the market promising to bolster hospitals’ finances by increasing revenue. But that’s not the case for San Francisco-based Midstream Health. For most health
The first antimalarial developed specifically for babies is a step closer to reaching parts of the world where malaria is endemic. The World Health Organization has completed its review of
Legacy patient support is no longer fit for purpose. For too long, fragmented manual systems have created data silos and delays, leading to lower adherence rates and refills, decreased patient
Oncology remains one of the most innovative and rapidly advancing fields in medicine. From chemotherapy to immunotherapy to the rise of personalized treatment, each breakthrough has brought us closer to
The GLP-1 craze is undeniable, with advertising for the injectables flooding our screens and public spaces, restaurants offering GLP-1-friendly menus, and providers restructuring care models around their use. About 12%
Biotechnology-focused venture capital firm Kurma Partners has closed a new fund with €215 million (about $252 million) in fresh capital to deploy across up to 20 young companies in the
About 12% of claims were denied in 2024, leading to $262 billion in lost revenue to providers. Providers spend about $26 billion annually in recovering denied claims, but only 70%
When James Van Der Beek announced he had been diagnosed with colorectal cancer, it was the kind of news that stunned many of us. I grew up watching Dawson’s Creek,
For those born with a particular type of hearing loss, the main treatment option has been mechanical: an implant that turns sound into electrical signals that stimulate the auditory nerve,
The AI Health Fund launched a new residency program this week called Treehub, which aims to fund early-stage healthcare AI startups coming out of academic labs. The program will run
